SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,209,796 | +95.8% | 138,832 | +122.1% | 0.00% | +100.0% |
| Q2 2023 | $1,639,170 | +251.5% | 62,516 | +245.1% | 0.00% | +100.0% |
| Q1 2023 | $466,306 | +14.8% | 18,116 | +16.0% | 0.00% | 0.0% |
| Q4 2022 | $406,172 | -4.2% | 15,616 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $424,000 | +10.4% | 15,616 | 0.0% | 0.00% | – |
| Q2 2022 | $384,000 | -68.2% | 15,616 | -27.1% | 0.00% | -100.0% |
| Q1 2022 | $1,209,000 | -8.9% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,327,000 | -2.4% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,359,000 | -25.9% | 21,416 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $1,835,000 | +16.4% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,576,000 | +11.9% | 21,416 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $1,409,000 | – | 19,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |